开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2221294, encodeId=0a0122212942f, content=Reviewers Assigned一般要等多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83bb9318441, createdName=ms3000000392392807, createdTime=Mon Aug 19 12:29:21 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184499, encodeId=60cf21844990a, content=分配编辑第6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ef12824121, createdName=zhu.jie4, createdTime=Sun Jan 28 21:35:15 CST 2024, time=2024-01-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210448, encodeId=7f3522104485f, content=投稿1周了还是new submission，连editor assigned都没有，这个情况该怎么办？改投其他杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erBl0d8oBibZdXpVWnYRM6hthyFO8klUkNO10cm3N6YNeztr9vatYzJk1wDmSc5N4kiciamgleIh2Lkw/132, createdBy=71f05229929, createdName=知微, createdTime=Tue Jun 18 11:02:54 CST 2024, time=2024-06-18, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2214333, encodeId=3e7c2214333b4, content=偏重的研究方向：癌症生物学;Cancer 经验分享：new submittion 7days后，editor assigned 第一天锦鲤保佑🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79a19302650, createdName=ms4000000305085280, createdTime=Wed Jul 10 23:32:35 CST 2024, time=2024-07-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2137833, encodeId=1faa213e8339c, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤药理 经验分享：投稿editor assign十天了，还没动静。是不是这个阶段时间长的最后都被拒稿了？烦请各位大神给个建议，如果不行我还是尽快改投了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c7d8270114, createdName=ms7000000085673920, createdTime=Fri May 19 09:27:21 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173906, encodeId=b00e21e3906d7, content=editor assigned10几天，还没有任何消息，感觉审稿速度与描述严重不符, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6645408637, createdName=ms4000000849190076, createdTime=Sat Dec 09 19:13:59 CST 2023, time=2023-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191383, encodeId=000f2191383fc, content=偏重的研究方向：神经科学 经验分享：黑马期刊！对生信也是很友好的！审稿速度贼快，接收范围也很广泛，发文量很稳定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/4b5344f5cf1649fa949d74b06c02814f-Ihby6jG1IuS8.jpg, createdBy=b89a9198980, createdName=蔚欣18389577351, createdTime=Wed Mar 06 11:13:21 CST 2024, time=2024-03-06, status=1, ipAttribution=广西)]

2022-08-13 124d2c45m98暂无昵称

edditor assigned 15天了，大家一般都多久啊？

0 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2221294, encodeId=0a0122212942f, content=Reviewers Assigned一般要等多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83bb9318441, createdName=ms3000000392392807, createdTime=Mon Aug 19 12:29:21 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184499, encodeId=60cf21844990a, content=分配编辑第6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ef12824121, createdName=zhu.jie4, createdTime=Sun Jan 28 21:35:15 CST 2024, time=2024-01-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210448, encodeId=7f3522104485f, content=投稿1周了还是new submission，连editor assigned都没有，这个情况该怎么办？改投其他杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erBl0d8oBibZdXpVWnYRM6hthyFO8klUkNO10cm3N6YNeztr9vatYzJk1wDmSc5N4kiciamgleIh2Lkw/132, createdBy=71f05229929, createdName=知微, createdTime=Tue Jun 18 11:02:54 CST 2024, time=2024-06-18, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2214333, encodeId=3e7c2214333b4, content=偏重的研究方向：癌症生物学;Cancer 经验分享：new submittion 7days后，editor assigned 第一天锦鲤保佑🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79a19302650, createdName=ms4000000305085280, createdTime=Wed Jul 10 23:32:35 CST 2024, time=2024-07-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2137833, encodeId=1faa213e8339c, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤药理 经验分享：投稿editor assign十天了，还没动静。是不是这个阶段时间长的最后都被拒稿了？烦请各位大神给个建议，如果不行我还是尽快改投了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c7d8270114, createdName=ms7000000085673920, createdTime=Fri May 19 09:27:21 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173906, encodeId=b00e21e3906d7, content=editor assigned10几天，还没有任何消息，感觉审稿速度与描述严重不符, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6645408637, createdName=ms4000000849190076, createdTime=Sat Dec 09 19:13:59 CST 2023, time=2023-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191383, encodeId=000f2191383fc, content=偏重的研究方向：神经科学 经验分享：黑马期刊！对生信也是很友好的！审稿速度贼快，接收范围也很广泛，发文量很稳定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/4b5344f5cf1649fa949d74b06c02814f-Ihby6jG1IuS8.jpg, createdBy=b89a9198980, createdName=蔚欣18389577351, createdTime=Wed Mar 06 11:13:21 CST 2024, time=2024-03-06, status=1, ipAttribution=广西)]

2024-08-21 ms9000001819006819 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：无

82 0

[GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2221294, encodeId=0a0122212942f, content=Reviewers Assigned一般要等多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83bb9318441, createdName=ms3000000392392807, createdTime=Mon Aug 19 12:29:21 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184499, encodeId=60cf21844990a, content=分配编辑第6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ef12824121, createdName=zhu.jie4, createdTime=Sun Jan 28 21:35:15 CST 2024, time=2024-01-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210448, encodeId=7f3522104485f, content=投稿1周了还是new submission，连editor assigned都没有，这个情况该怎么办？改投其他杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erBl0d8oBibZdXpVWnYRM6hthyFO8klUkNO10cm3N6YNeztr9vatYzJk1wDmSc5N4kiciamgleIh2Lkw/132, createdBy=71f05229929, createdName=知微, createdTime=Tue Jun 18 11:02:54 CST 2024, time=2024-06-18, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2214333, encodeId=3e7c2214333b4, content=偏重的研究方向：癌症生物学;Cancer 经验分享：new submittion 7days后，editor assigned 第一天锦鲤保佑🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79a19302650, createdName=ms4000000305085280, createdTime=Wed Jul 10 23:32:35 CST 2024, time=2024-07-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2137833, encodeId=1faa213e8339c, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤药理 经验分享：投稿editor assign十天了，还没动静。是不是这个阶段时间长的最后都被拒稿了？烦请各位大神给个建议，如果不行我还是尽快改投了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c7d8270114, createdName=ms7000000085673920, createdTime=Fri May 19 09:27:21 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173906, encodeId=b00e21e3906d7, content=editor assigned10几天，还没有任何消息，感觉审稿速度与描述严重不符, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6645408637, createdName=ms4000000849190076, createdTime=Sat Dec 09 19:13:59 CST 2023, time=2023-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191383, encodeId=000f2191383fc, content=偏重的研究方向：神经科学 经验分享：黑马期刊！对生信也是很友好的！审稿速度贼快，接收范围也很广泛，发文量很稳定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/4b5344f5cf1649fa949d74b06c02814f-Ihby6jG1IuS8.jpg, createdBy=b89a9198980, createdName=蔚欣18389577351, createdTime=Wed Mar 06 11:13:21 CST 2024, time=2024-03-06, status=1, ipAttribution=广西)]

2024-08-19 whal 来自江苏省

偏重的研究方向：肿瘤药理
经验分享：急的慎投，十几天了还卡在editor assigned

78 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2221294, encodeId=0a0122212942f, content=Reviewers Assigned一般要等多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83bb9318441, createdName=ms3000000392392807, createdTime=Mon Aug 19 12:29:21 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184499, encodeId=60cf21844990a, content=分配编辑第6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ef12824121, createdName=zhu.jie4, createdTime=Sun Jan 28 21:35:15 CST 2024, time=2024-01-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210448, encodeId=7f3522104485f, content=投稿1周了还是new submission，连editor assigned都没有，这个情况该怎么办？改投其他杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erBl0d8oBibZdXpVWnYRM6hthyFO8klUkNO10cm3N6YNeztr9vatYzJk1wDmSc5N4kiciamgleIh2Lkw/132, createdBy=71f05229929, createdName=知微, createdTime=Tue Jun 18 11:02:54 CST 2024, time=2024-06-18, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2214333, encodeId=3e7c2214333b4, content=偏重的研究方向：癌症生物学;Cancer 经验分享：new submittion 7days后，editor assigned 第一天锦鲤保佑🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79a19302650, createdName=ms4000000305085280, createdTime=Wed Jul 10 23:32:35 CST 2024, time=2024-07-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2137833, encodeId=1faa213e8339c, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤药理 经验分享：投稿editor assign十天了，还没动静。是不是这个阶段时间长的最后都被拒稿了？烦请各位大神给个建议，如果不行我还是尽快改投了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c7d8270114, createdName=ms7000000085673920, createdTime=Fri May 19 09:27:21 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173906, encodeId=b00e21e3906d7, content=editor assigned10几天，还没有任何消息，感觉审稿速度与描述严重不符, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6645408637, createdName=ms4000000849190076, createdTime=Sat Dec 09 19:13:59 CST 2023, time=2023-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191383, encodeId=000f2191383fc, content=偏重的研究方向：神经科学 经验分享：黑马期刊！对生信也是很友好的！审稿速度贼快，接收范围也很广泛，发文量很稳定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/4b5344f5cf1649fa949d74b06c02814f-Ihby6jG1IuS8.jpg, createdBy=b89a9198980, createdName=蔚欣18389577351, createdTime=Wed Mar 06 11:13:21 CST 2024, time=2024-03-06, status=1, ipAttribution=广西)]

2024-08-19 ms3000000392392807 来自广东省

Reviewers Assigned一般要等多久呢

36 0

[GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2221294, encodeId=0a0122212942f, content=Reviewers Assigned一般要等多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83bb9318441, createdName=ms3000000392392807, createdTime=Mon Aug 19 12:29:21 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184499, encodeId=60cf21844990a, content=分配编辑第6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ef12824121, createdName=zhu.jie4, createdTime=Sun Jan 28 21:35:15 CST 2024, time=2024-01-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210448, encodeId=7f3522104485f, content=投稿1周了还是new submission，连editor assigned都没有，这个情况该怎么办？改投其他杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erBl0d8oBibZdXpVWnYRM6hthyFO8klUkNO10cm3N6YNeztr9vatYzJk1wDmSc5N4kiciamgleIh2Lkw/132, createdBy=71f05229929, createdName=知微, createdTime=Tue Jun 18 11:02:54 CST 2024, time=2024-06-18, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2214333, encodeId=3e7c2214333b4, content=偏重的研究方向：癌症生物学;Cancer 经验分享：new submittion 7days后，editor assigned 第一天锦鲤保佑🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79a19302650, createdName=ms4000000305085280, createdTime=Wed Jul 10 23:32:35 CST 2024, time=2024-07-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2137833, encodeId=1faa213e8339c, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤药理 经验分享：投稿editor assign十天了，还没动静。是不是这个阶段时间长的最后都被拒稿了？烦请各位大神给个建议，如果不行我还是尽快改投了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c7d8270114, createdName=ms7000000085673920, createdTime=Fri May 19 09:27:21 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173906, encodeId=b00e21e3906d7, content=editor assigned10几天，还没有任何消息，感觉审稿速度与描述严重不符, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6645408637, createdName=ms4000000849190076, createdTime=Sat Dec 09 19:13:59 CST 2023, time=2023-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191383, encodeId=000f2191383fc, content=偏重的研究方向：神经科学 经验分享：黑马期刊！对生信也是很友好的！审稿速度贼快，接收范围也很广泛，发文量很稳定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/4b5344f5cf1649fa949d74b06c02814f-Ihby6jG1IuS8.jpg, createdBy=b89a9198980, createdName=蔚欣18389577351, createdTime=Wed Mar 06 11:13:21 CST 2024, time=2024-03-06, status=1, ipAttribution=广西)]

2024-01-28 zhu.jie4 来自上海

分配编辑第6天

91 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2221294, encodeId=0a0122212942f, content=Reviewers Assigned一般要等多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83bb9318441, createdName=ms3000000392392807, createdTime=Mon Aug 19 12:29:21 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184499, encodeId=60cf21844990a, content=分配编辑第6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ef12824121, createdName=zhu.jie4, createdTime=Sun Jan 28 21:35:15 CST 2024, time=2024-01-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210448, encodeId=7f3522104485f, content=投稿1周了还是new submission，连editor assigned都没有，这个情况该怎么办？改投其他杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erBl0d8oBibZdXpVWnYRM6hthyFO8klUkNO10cm3N6YNeztr9vatYzJk1wDmSc5N4kiciamgleIh2Lkw/132, createdBy=71f05229929, createdName=知微, createdTime=Tue Jun 18 11:02:54 CST 2024, time=2024-06-18, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2214333, encodeId=3e7c2214333b4, content=偏重的研究方向：癌症生物学;Cancer 经验分享：new submittion 7days后，editor assigned 第一天锦鲤保佑🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79a19302650, createdName=ms4000000305085280, createdTime=Wed Jul 10 23:32:35 CST 2024, time=2024-07-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2137833, encodeId=1faa213e8339c, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤药理 经验分享：投稿editor assign十天了，还没动静。是不是这个阶段时间长的最后都被拒稿了？烦请各位大神给个建议，如果不行我还是尽快改投了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c7d8270114, createdName=ms7000000085673920, createdTime=Fri May 19 09:27:21 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173906, encodeId=b00e21e3906d7, content=editor assigned10几天，还没有任何消息，感觉审稿速度与描述严重不符, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6645408637, createdName=ms4000000849190076, createdTime=Sat Dec 09 19:13:59 CST 2023, time=2023-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191383, encodeId=000f2191383fc, content=偏重的研究方向：神经科学 经验分享：黑马期刊！对生信也是很友好的！审稿速度贼快，接收范围也很广泛，发文量很稳定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/4b5344f5cf1649fa949d74b06c02814f-Ihby6jG1IuS8.jpg, createdBy=b89a9198980, createdName=蔚欣18389577351, createdTime=Wed Mar 06 11:13:21 CST 2024, time=2024-03-06, status=1, ipAttribution=广西)]

2024-06-18 知微来自台湾省

投稿1周了还是new submission，连editor assigned都没有，这个情况该怎么办？改投其他杂志吗

65 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2221294, encodeId=0a0122212942f, content=Reviewers Assigned一般要等多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83bb9318441, createdName=ms3000000392392807, createdTime=Mon Aug 19 12:29:21 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184499, encodeId=60cf21844990a, content=分配编辑第6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ef12824121, createdName=zhu.jie4, createdTime=Sun Jan 28 21:35:15 CST 2024, time=2024-01-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210448, encodeId=7f3522104485f, content=投稿1周了还是new submission，连editor assigned都没有，这个情况该怎么办？改投其他杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erBl0d8oBibZdXpVWnYRM6hthyFO8klUkNO10cm3N6YNeztr9vatYzJk1wDmSc5N4kiciamgleIh2Lkw/132, createdBy=71f05229929, createdName=知微, createdTime=Tue Jun 18 11:02:54 CST 2024, time=2024-06-18, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2214333, encodeId=3e7c2214333b4, content=偏重的研究方向：癌症生物学;Cancer 经验分享：new submittion 7days后，editor assigned 第一天锦鲤保佑🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79a19302650, createdName=ms4000000305085280, createdTime=Wed Jul 10 23:32:35 CST 2024, time=2024-07-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2137833, encodeId=1faa213e8339c, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤药理 经验分享：投稿editor assign十天了，还没动静。是不是这个阶段时间长的最后都被拒稿了？烦请各位大神给个建议，如果不行我还是尽快改投了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c7d8270114, createdName=ms7000000085673920, createdTime=Fri May 19 09:27:21 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173906, encodeId=b00e21e3906d7, content=editor assigned10几天，还没有任何消息，感觉审稿速度与描述严重不符, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6645408637, createdName=ms4000000849190076, createdTime=Sat Dec 09 19:13:59 CST 2023, time=2023-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191383, encodeId=000f2191383fc, content=偏重的研究方向：神经科学 经验分享：黑马期刊！对生信也是很友好的！审稿速度贼快，接收范围也很广泛，发文量很稳定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/4b5344f5cf1649fa949d74b06c02814f-Ihby6jG1IuS8.jpg, createdBy=b89a9198980, createdName=蔚欣18389577351, createdTime=Wed Mar 06 11:13:21 CST 2024, time=2024-03-06, status=1, ipAttribution=广西)]

2024-07-10 ms4000000305085280 来自天津

偏重的研究方向：癌症生物学;Cancer
经验分享：new submittion 7days后，editor assigned 第一天锦鲤保佑🙏

57 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2221294, encodeId=0a0122212942f, content=Reviewers Assigned一般要等多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83bb9318441, createdName=ms3000000392392807, createdTime=Mon Aug 19 12:29:21 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184499, encodeId=60cf21844990a, content=分配编辑第6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ef12824121, createdName=zhu.jie4, createdTime=Sun Jan 28 21:35:15 CST 2024, time=2024-01-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210448, encodeId=7f3522104485f, content=投稿1周了还是new submission，连editor assigned都没有，这个情况该怎么办？改投其他杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erBl0d8oBibZdXpVWnYRM6hthyFO8klUkNO10cm3N6YNeztr9vatYzJk1wDmSc5N4kiciamgleIh2Lkw/132, createdBy=71f05229929, createdName=知微, createdTime=Tue Jun 18 11:02:54 CST 2024, time=2024-06-18, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2214333, encodeId=3e7c2214333b4, content=偏重的研究方向：癌症生物学;Cancer 经验分享：new submittion 7days后，editor assigned 第一天锦鲤保佑🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79a19302650, createdName=ms4000000305085280, createdTime=Wed Jul 10 23:32:35 CST 2024, time=2024-07-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2137833, encodeId=1faa213e8339c, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤药理 经验分享：投稿editor assign十天了，还没动静。是不是这个阶段时间长的最后都被拒稿了？烦请各位大神给个建议，如果不行我还是尽快改投了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c7d8270114, createdName=ms7000000085673920, createdTime=Fri May 19 09:27:21 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173906, encodeId=b00e21e3906d7, content=editor assigned10几天，还没有任何消息，感觉审稿速度与描述严重不符, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6645408637, createdName=ms4000000849190076, createdTime=Sat Dec 09 19:13:59 CST 2023, time=2023-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191383, encodeId=000f2191383fc, content=偏重的研究方向：神经科学 经验分享：黑马期刊！对生信也是很友好的！审稿速度贼快，接收范围也很广泛，发文量很稳定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/4b5344f5cf1649fa949d74b06c02814f-Ihby6jG1IuS8.jpg, createdBy=b89a9198980, createdName=蔚欣18389577351, createdTime=Wed Mar 06 11:13:21 CST 2024, time=2024-03-06, status=1, ipAttribution=广西)]

2023-05-19 ms7000000085673920 来自北京

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤药理
经验分享：投稿editor assign十天了，还没动静。是不是这个阶段时间长的最后都被拒稿了？烦请各位大神给个建议，如果不行我还是尽快改投了~

109 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2221294, encodeId=0a0122212942f, content=Reviewers Assigned一般要等多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83bb9318441, createdName=ms3000000392392807, createdTime=Mon Aug 19 12:29:21 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184499, encodeId=60cf21844990a, content=分配编辑第6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ef12824121, createdName=zhu.jie4, createdTime=Sun Jan 28 21:35:15 CST 2024, time=2024-01-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210448, encodeId=7f3522104485f, content=投稿1周了还是new submission，连editor assigned都没有，这个情况该怎么办？改投其他杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erBl0d8oBibZdXpVWnYRM6hthyFO8klUkNO10cm3N6YNeztr9vatYzJk1wDmSc5N4kiciamgleIh2Lkw/132, createdBy=71f05229929, createdName=知微, createdTime=Tue Jun 18 11:02:54 CST 2024, time=2024-06-18, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2214333, encodeId=3e7c2214333b4, content=偏重的研究方向：癌症生物学;Cancer 经验分享：new submittion 7days后，editor assigned 第一天锦鲤保佑🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79a19302650, createdName=ms4000000305085280, createdTime=Wed Jul 10 23:32:35 CST 2024, time=2024-07-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2137833, encodeId=1faa213e8339c, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤药理 经验分享：投稿editor assign十天了，还没动静。是不是这个阶段时间长的最后都被拒稿了？烦请各位大神给个建议，如果不行我还是尽快改投了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c7d8270114, createdName=ms7000000085673920, createdTime=Fri May 19 09:27:21 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173906, encodeId=b00e21e3906d7, content=editor assigned10几天，还没有任何消息，感觉审稿速度与描述严重不符, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6645408637, createdName=ms4000000849190076, createdTime=Sat Dec 09 19:13:59 CST 2023, time=2023-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191383, encodeId=000f2191383fc, content=偏重的研究方向：神经科学 经验分享：黑马期刊！对生信也是很友好的！审稿速度贼快，接收范围也很广泛，发文量很稳定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/4b5344f5cf1649fa949d74b06c02814f-Ihby6jG1IuS8.jpg, createdBy=b89a9198980, createdName=蔚欣18389577351, createdTime=Wed Mar 06 11:13:21 CST 2024, time=2024-03-06, status=1, ipAttribution=广西)]

2023-12-09 ms4000000849190076 来自江苏省

editor assigned10几天，还没有任何消息，感觉审稿速度与描述严重不符

92 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2221294, encodeId=0a0122212942f, content=Reviewers Assigned一般要等多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83bb9318441, createdName=ms3000000392392807, createdTime=Mon Aug 19 12:29:21 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184499, encodeId=60cf21844990a, content=分配编辑第6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ef12824121, createdName=zhu.jie4, createdTime=Sun Jan 28 21:35:15 CST 2024, time=2024-01-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210448, encodeId=7f3522104485f, content=投稿1周了还是new submission，连editor assigned都没有，这个情况该怎么办？改投其他杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erBl0d8oBibZdXpVWnYRM6hthyFO8klUkNO10cm3N6YNeztr9vatYzJk1wDmSc5N4kiciamgleIh2Lkw/132, createdBy=71f05229929, createdName=知微, createdTime=Tue Jun 18 11:02:54 CST 2024, time=2024-06-18, status=1, ipAttribution=台湾省), GetPortalCommentsPageByObjectIdResponse(id=2214333, encodeId=3e7c2214333b4, content=偏重的研究方向：癌症生物学;Cancer 经验分享：new submittion 7days后，editor assigned 第一天锦鲤保佑🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79a19302650, createdName=ms4000000305085280, createdTime=Wed Jul 10 23:32:35 CST 2024, time=2024-07-10, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2137833, encodeId=1faa213e8339c, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤药理 经验分享：投稿editor assign十天了，还没动静。是不是这个阶段时间长的最后都被拒稿了？烦请各位大神给个建议，如果不行我还是尽快改投了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c7d8270114, createdName=ms7000000085673920, createdTime=Fri May 19 09:27:21 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2173906, encodeId=b00e21e3906d7, content=editor assigned10几天，还没有任何消息，感觉审稿速度与描述严重不符, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6645408637, createdName=ms4000000849190076, createdTime=Sat Dec 09 19:13:59 CST 2023, time=2023-12-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191383, encodeId=000f2191383fc, content=偏重的研究方向：神经科学 经验分享：黑马期刊！对生信也是很友好的！审稿速度贼快，接收范围也很广泛，发文量很稳定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/4b5344f5cf1649fa949d74b06c02814f-Ihby6jG1IuS8.jpg, createdBy=b89a9198980, createdName=蔚欣18389577351, createdTime=Wed Mar 06 11:13:21 CST 2024, time=2024-03-06, status=1, ipAttribution=广西)]

2024-03-06 蔚欣18389577351 来自广西

偏重的研究方向：神经科学
经验分享：黑马期刊！对生信也是很友好的！审稿速度贼快，接收范围也很广泛，发文量很稳定

83 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务